Mostrar el registro sencillo del ítem

dc.contributor.authorDuran Sotuela, Alejandro*
dc.contributor.authorFernández Moreno, Mercedes*
dc.contributor.authorSuárez Ulloa, Victoria*
dc.contributor.authorVázquez-García, J.*
dc.contributor.authorRelaño Fernández, Sara María*
dc.contributor.authorHermida Gómez, Tamara *
dc.contributor.authorBalboa Barreiro, Vanesa*
dc.contributor.authorLourido-Salas, L.*
dc.contributor.authorCalamia ., Valentina*
dc.contributor.authorFernández Puente, Patricia *
dc.contributor.authorRuiz Romero, Cristina *
dc.contributor.authorFernández Tajes, Juan*
dc.contributor.authorVaamonde García, Carlos *
dc.contributor.authorDe Andrés González, Mª Carmen*
dc.contributor.authorOreiro, N.*
dc.contributor.authorBlanco García, Francisco*
dc.contributor.authorRego Pérez, Ignacio *
dc.date.accessioned2025-09-05T08:20:25Z
dc.date.available2025-09-05T08:20:25Z
dc.date.issued2023
dc.identifier.citationDurán-Sotuela A, Fernandez-Moreno M, Suárez-Ulloa V, Vázquez-García J, Relaño S, Hermida-Gómez T, et al. A meta-analysis and a functional study support the influence of mtDNA variant m.16519C on the risk of rapid progression of knee osteoarthritis. Annals of the Rheumatic Diseases. 2023;82(7):974-84.
dc.identifier.issn1468-2060
dc.identifier.otherhttps://portalcientifico.sergas.gal//documentos/648600d6a219857f1d7895a0
dc.identifier.urihttp://hdl.handle.net/20.500.11940/20983
dc.description.abstractObjectives To identify mitochondrial DNA (mtDNA) genetic variants associated with the risk of rapid progression of knee osteoarthritis (OA) and to characterise their functional significance using a cellular model of transmitochondrial cybrids. Methods Three prospective cohorts contributed participants. The osteoarthritis initiative (OAI) included 1095 subjects, the Cohort Hip and Cohort Knee included 373 and 326 came from the PROspective Cohort of Osteoarthritis from A Coruña. mtDNA variants were screened in an initial subset of 450 subjects from the OAI by in-depth sequencing of mtDNA. A meta-analysis of the three cohorts was performed. A model of cybrids was constructed to study the functional consequences of harbouring the risk mtDNA variant by assessing: mtDNA copy number, mitochondrial biosynthesis, mitochondrial fission and fusion, mitochondrial reactive oxygen species (ROS), oxidative stress, autophagy and a whole transcriptome analysis by RNA-sequencing. Results mtDNA variant m.16519C is over-represented in rapid progressors (combined OR 1.546; 95% CI 1.163 to 2.054; p=0.0027). Cybrids with this variant show increased mtDNA copy number and decreased mitochondrial biosynthesis; they produce higher amounts of mitochondrial ROS, are less resistant to oxidative stress, show a lower expression of the mitochondrial fission-related gene fission mitochondrial 1 and an impairment of autophagic flux. In addition, its presence modulates the transcriptome of cybrids, especially in terms of inflammation, where interleukin 6 emerges as one of the most differentially expressed genes. Conclusions The presence of the mtDNA variant m.16519C increases the risk of rapid progression of knee OA. Among the most modulated biological processes associated with this variant, inflammation and negative regulation of cellular process stand out. The design of therapies based on the maintenance of mitochondrial function is recommended.
dc.description.sponsorshipThe Osteoarthritis Initiative (OAI) is a public- private partnership comprising five contracts (N01- AR- 2- 2258; N01- AR- 2- 2259; N01- AR- 2- 2260; N01- AR- 2- 2261; N01- AR- 2- 2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Pfizer; Novartis Pharmaceuticals; Merck Research Laboratories and GlaxoSmithKline. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. CHECK- cohort study is funded by the Dutch Arthritis Association. It is led by a steering committee comprising 16 members with expertise in different fields of OA. It is chaired by Professor J W J Bijlsma and coordinated by J Wesseling, MSc. The following institutions are involved: Erasmus Medical Center Rotterdam; Kennemer Gasthuis Haarlem; Leiden University Medical Center; Maastrich University Medical Center; Martini Hospital Groningen/Allied Health Care Center for Rheum and Rehabilitation Groningen; Medical Spectrum Twente Enschede/Ziekenhuisgroep Twente Almelo; Reade, formerly Jan van Breemen Institute/VU Medical Center Amsterdam; St Maartens- kliniek Nijmegen; University Medical Center Utrecht and Wilhelmina Hospital Assen. ISCIII ('PI17/00210', 'PI19/01206', 'PI19/01213', 'PI20/00614', 'RICORS RD21/0002/0009'), co- funded by ERDF/ESF, 'A way to make Europe'/'Investing in your future'). Xunta de Galicia ('IN607A2021/07'). IR- P is supported by Contrato Miguel Servet- II Fondo de Investigacion Sanitaria (CPII17/00026) estabilizado SERGAS. JV- G is supported by grant IN606A- 2022/048 from Xunta de Galicia, Spain. LL- S is supported by contrato Sara Borrell Fondo de Investigacion Sanitaria (CD19/00229). The Biomedical Research Networking Center (CIBER) is an initiative from ISCIII
dc.languageeng
dc.rightsAttribution-NonCommercial 4.0 International (CC BY-NC 4.0)*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subject.meshHumans *
dc.subject.meshDNA, Mitochondrial *
dc.subject.meshOsteoarthritis, Knee *
dc.subject.meshReactive Oxygen Species *
dc.subject.meshProspective Studies *
dc.subject.meshMitochondria *
dc.subject.meshInflammation *
dc.titleA meta-analysis and a functional study support the influence of mtDNA variant m.16519C on the risk of rapid progression of knee osteoarthritis
dc.typeArtigo
dc.authorsophosDurán-Sotuela, A.; Fernandez-Moreno, M.; Suárez-Ulloa, V.; Vázquez-García, J.; Relaño, S.; Hermida-Gómez, T.; Balboa-Barreiro, V.; Lourido-Salas, L.; Calamia, V.; Fernandez-Puente, P.; Ruiz-Romero, C.; Fernández-Tajes, J.; Vaamonde-García, C.; De Andrés, M.C.; Oreiro, N.; Blanco, F.J.; Rego-Perez, I.
dc.identifier.doi10.1136/ard-2022-223570
dc.identifier.sophos648600d6a219857f1d7895a0
dc.issue.number7
dc.journal.titleAnnals of the Rheumatic Diseases*
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Biomédica de A Coruña (INIBIC)
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Unidade de investigación
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Informática, sistemas e tecnoloxías da información
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Epidemioloxía
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Unidade de investigación
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Biomédica de A Coruña (INIBIC)
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Unidade de investigación
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Unidade de investigación
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Unidade de investigación
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Biomédica de A Coruña (INIBIC)::Unidade de investigación
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Unidade de investigación
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Biomédica de A Coruña (INIBIC)::Unidade de investigación
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Reumatoloxía
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Unidade de investigación
dc.page.initial974
dc.page.final984
dc.relation.projectIDNational Institutes of Health, a branch of the Department of Health and Human Services
dc.relation.projectIDPfizer
dc.relation.projectIDNovartis Pharmaceuticals
dc.relation.projectIDMerck Research Laboratories
dc.relation.projectIDGlaxoSmithKline
dc.relation.projectIDDutch Arthritis Association
dc.relation.projectIDISCIII [PI17/00210, PI19/01206, PI19/01213, PI20/00614, RICORS RD21/0002/0009]
dc.relation.projectIDERDF/ESF, 'A way to make Europe'/'Investing in your future'
dc.relation.projectIDXunta de Galicia [IN607A2021/07, CPII17/00026]
dc.relation.projectIDContrato Miguel Servet- II Fondo de Investigacion Sanitaria [IN606A- 2022/048]
dc.relation.projectIDcontrato Sara Borrell Fondo de Investigacion Sanitaria [CD19/00229]
dc.relation.publisherversionhttps://doi.org/10.1136/ard-2022-223570
dc.rights.accessRightsopenAccess*
dc.subject.keywordAS A Coruña
dc.subject.keywordINIBIC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordAS A Coruña
dc.subject.keywordINIBIC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordAS A Coruña
dc.subject.keywordINIBIC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordAS A Coruña
dc.subject.keywordINIBIC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo Original
dc.volume.number82


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)